Building the evidence base--the Zassi Bowel Management System

Area of Science:

• Gastroenterology
• Infectious Disease Control
• Medical Device Evaluation

Background:

• Uncontrolled faecal incontinence (FI) secondary to diarrhoea compromises perianal skin integrity.
• Diarrhoea and FI increase risks of hospital-acquired infections and cross-contamination.
• Maintaining skin integrity and wound sterility is crucial in patient care.

Purpose of the Study:

• To evaluate the Zassi Bowel Management System (ZBMS) for managing diarrhoea and FI.
• To assess the ZBMS's efficacy in high-risk patient populations.
• To determine the system's role in preventing skin breakdown and cross-infection.

Main Methods:

• Evaluation of the Zassi Bowel Management System (ZBMS).
• Focus on patient populations with complete dependence or severe, uncontrolled diarrhoea.
• Assessment of the system's impact on skin integrity, wound healing, and infection risk.

Main Results:

• The ZBMS is designed for managing diarrhoea and faecal incontinence.
• It addresses risks to skin integrity and wound sterility.
• The system is indicated for completely dependent patients or those with severe diarrhoea.

Conclusions:

• The Zassi Bowel Management System (ZBMS) provides a management strategy for challenging faecal incontinence cases.
• It aims to mitigate risks associated with uncontrolled diarrhoea, including skin breakdown and cross-infection.
• The ZBMS is a potential solution for improving patient outcomes in specific clinical scenarios.